Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It operates in two segments, Pharmaceutical and Chemical Manufacturing. The company offers general health therapeutic products, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, and anti-thyroid. It also provides cough and cold control, digestives, neurotonics, nutritional supplements, topical anti-biotic/anti-microbial, and other specialty drugs. The company sells its products under the Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin brands. It distributes its products through agents, stockiest, doctors, and retailers. The company was incorporated in 1984 and is based in Mumbai, India.
| Current Price | ₹158.45 |
|---|---|
| Market Cap | ₹93 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Products |
| P/E Ratio | 12.5 |
| Return on Equity | 9.94% |
| 52-Week Range | ₹109.00 – ₹186.70 |
| Beta (1Y) | 0.48 |
| Dividend Yield | 0.00% |
1. Pharmaceutical-35.6% 2. Chemical Manufacturing-64.4%
Makers Laboratories Ltd. is trading at ₹158.45, with a market capitalisation of ₹93 Cr.
Makers Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Products).
Makers Laboratories Ltd. has a P/E of 12.5 and a return on equity of 9.94%.